Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib

Publisher： Karger

E-ISSN： 1662-6575|4|1|192-197

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.4, Iss.1, 2011-04, pp. : 192-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Imatinib Mesylate Combined with Granulocyte Colony-Stimulating Factor on Leukaemic Blast Cells Derived from Advanced-Stage Chronic Myelogenous Leukaemia Patients

By  

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 8-18

Karger

Access to resources Recommend Favorite

CD117 (c-kit) Expression on CD34+ Cells Participates in the Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia in the First Chronic Phase

By  

Acta Haematologica, Vol. 132, Iss. 2, 2014-02 ,pp. : 166-171

Karger

Access to resources Recommend Favorite

Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 109-114

Karger

Access to resources Recommend Favorite

Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy

By  

Acta Haematologica, Vol. 137, Iss. 3, 2017-04 ,pp. : 158-162

Karger

Access to resources Recommend Favorite

Changes in Expression of Apoptosis-Related Genes Are Linked to the Molecular Response to Imatinib Treatment in Chronic-Phase Chronic Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 117, Iss. 2, 2006-11 ,pp. : 83-90

Karger

Access to resources Recommend Favorite